However, due to the insufficient number of patients in each subgroup, the interesting issues of whether the prognostic performance of TERT mutations may vary with tumor stage, treatment, and/or the cause of HCC should be confirmed in larger studies. The gene discussed is TERT; the disease is hepatocellular carcinoma.